Working… Menu

Trial of Vitamin C as Add on Therapy for Children With Idiopathic Epilepsy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02369822
Recruitment Status : Unknown
Verified February 2015 by Shaymaa Maher Deifalla, Ain Shams University.
Recruitment status was:  Active, not recruiting
First Posted : February 24, 2015
Last Update Posted : February 24, 2015
Information provided by (Responsible Party):
Shaymaa Maher Deifalla, Ain Shams University

Brief Summary:
There are no solid treatment guidelines for idiopathic intractable epilepsy in children. The investigators propose that vitamin C being an antioxidant will improve seizure frequency and EEG in children with idiopathic intractable epilepsy.

Condition or disease Intervention/treatment Phase
Idiopathic Epilepsy Dietary Supplement: Vitamin C Phase 2

Detailed Description:
Is vitamin C; being an antioxidant based on the hypothesis of oxidative stress as a provocation factor for idiopathic epilepsy low in those with idiopathic epilepsy, and is it lower in those with refractory than those with newly diagnosed? Will vitamin C supplementation for 1 month be efficient to raise the vitamin C level and will it improve seizures and EEG findings in those with idiopathic epilepsy?

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 60 participants
Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Trial of Vitamin C as Add on Therapy for Children With Idiopathic Epilepsy
Study Start Date : February 2015
Estimated Primary Completion Date : September 2015
Estimated Study Completion Date : March 2016

Arm Intervention/treatment
Experimental: Vitamin C supplemented
patients with refractory idiopathic epilepsy will receive vitamin C supplement according to age for 1 month
Dietary Supplement: Vitamin C
those who are 2-3 years will receive 400 mg/day, 4-8 years will receive 500 mg/day, those who are 9-13 years will receive 1000 mg/day, and from 14-16 years will receive 1500 mg/day

No Intervention: None supplemented
followed up for 1 month

Primary Outcome Measures :
  1. Seizure severity and frequency, EEG findings [ Time Frame: up to 30 days ]
    Seizure severity based on the Chalfont seizre severity scale and daily seizure frequency will be measured before and 30 days after vitamin C supplementation in children with intractable idiopathic epilepsy

Secondary Outcome Measures :
  1. vitamin C level in children with epilepsy [ Time Frame: 6 months ]
    children with epilepsy will be recruited over a period of 6 months and we will measure vitamin C level in their blood

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   2 Years to 16 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Normal neuroimaging

Exclusion Criteria:

  • Developmental delay.
  • Suspected metabolic problems.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT02369822

Layout table for location information
Shaymaa Maher Deifalla
Cairo, Nasr City, Egypt
Sponsors and Collaborators
Ain Shams University
Layout table for investigator information
Study Director: Iman A Elagouza, A Professor Faculty of Medicine, Ain Shams University

Layout table for additonal information
Responsible Party: Shaymaa Maher Deifalla, Lecturer of Pediatrics, Faculty of Medicine, Ain Shams University Identifier: NCT02369822     History of Changes
Other Study ID Numbers: Vitamin C, Children, Epilepsy
First Posted: February 24, 2015    Key Record Dates
Last Update Posted: February 24, 2015
Last Verified: February 2015
Keywords provided by Shaymaa Maher Deifalla, Ain Shams University:
Vitamin C
convulsions status
Additional relevant MeSH terms:
Layout table for MeSH terms
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Ascorbic Acid
Growth Substances
Physiological Effects of Drugs
Molecular Mechanisms of Pharmacological Action
Protective Agents